Collegium Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,207	892	908	729	572	566
Market Cap Growth	27.00%	-1.72%	24.61%	27.51%	0.93%	-7.90%
Enterprise Value	1,759	1,736	1,282	1,288	640	657
Last Close Price	38.20	27.60	27.80	21.40	17.10	16.00
PE Ratio	24.24	13.35	20.84	-	9.09	25.89
PS Ratio	1.87	1.46	1.77	1.68	2.35	2.23
PB Ratio	5.16	4.04	5.14	4.00	3.20	3.72
P/FCF Ratio	4.90	4.54	3.66	6.35	6.40	7.84
P/OCF Ratio	4.87	4.51	3.65	6.27	6.28	7.37
EV/Sales Ratio	2.74	2.85	2.50	2.97	2.63	2.59
EV/EBITDA Ratio	5.11	4.87	4.17	7.99	7.98	6.83
EV/EBIT Ratio	11.85	9.00	7.44	36.13	32.76	14.30
EV/FCF Ratio	7.14	8.84	5.17	11.23	7.16	9.10
Debt / Equity Ratio	3.41	4.28	3.45	3.64	1.27	1.43
Debt / EBITDA Ratio	2.31	2.63	1.96	4.04	2.75	2.21
Debt / FCF Ratio	3.24	4.82	2.46	5.78	2.55	3.02
Net Debt / Equity Ratio	2.37	3.57	1.86	2.75	0.36	0.50
Net Debt / EBITDA Ratio	1.62	2.22	1.07	3.11	0.79	0.79
Net Debt / FCF Ratio	2.25	4.02	1.33	4.37	0.71	1.05
Asset Turnover	0.47	0.45	0.49	0.50	0.41	0.65
Inventory Turnover	2.35	2.46	2.02	3.70	3.58	5.50
Quick Ratio	1.15	0.77	1.07	0.82	1.05	1.08
Current Ratio	1.36	0.95	1.17	0.97	1.13	1.16
Return on Equity (ROE)	22.96%	32.62%	24.68%	-12.57%	36.77%	19.56%
Return on Assets (ROA)	6.75%	8.89%	10.28%	2.55%	2.08%	7.40%
Return on Invested Capital (ROIC)	13.41%	17.46%	18.80%	7.58%	8.02%	50.15%
Return on Capital Employed (ROCE)	15.20%	17.30%	27.80%	5.10%	5.40%	13.90%
Earnings Yield	4.13%	7.49%	4.80%	-3.21%	11.00%	3.86%
FCF Yield	20.42%	22.01%	27.33%	15.74%	15.63%	12.76%
Buyback Yield / Dilution	13.26%	3.26%	-23.53%	17.58%	-16.77%	-5.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.